4.7 Article

Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022

期刊

EMERGING INFECTIOUS DISEASES
卷 29, 期 4, 页码 723-733

出版社

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2904.221628

关键词

-

向作者/读者索取更多资源

To assess the changes in SARS-CoV-2 spike binding antibody prevalence and its implications for immunologic protection against variants of concern, a prospective study was conducted in the Dominican Republic from March 2021 to August 2022, involving 2,300 patients with undifferentiated febrile illnesses. Serum samples were tested for spike antibodies and nasopharyngeal samples were tested for acute SARS-CoV-2 infection. The study found that geometric mean spike antibody titers significantly increased over time, and higher antibody levels were associated with reduced odds of acute infection, regardless of the viral strain. The combination of serologic and virologic screening could help monitor population immunologic markers and their impact on emerging variant transmission.
To assess changes in SARS-CoV-2 spike binding anti-body prevalence in the Dominican Republic and impli-cations for immunologic protection against variants of concern, we prospectively enrolled 2,300 patients with undifferentiated febrile illnesses in a study during March 2021-August 2022. We tested serum samples for spike antibodies and tested nasopharyngeal samples for acute SARS-CoV-2 infection using a reverse transcription PCR nucleic acid amplification test. Geometric mean spike an-tibody titers increased from 6.6 (95% CI 5.1-8.7) binding antibody units (BAU)/mL during March-June 2021 to 1,332 (95% CI 1,055-1,682) BAU/mL during May- August 2022. Multivariable binomial odds ratios for acute infection were 0.55 (95% CI 0.40-0.74), 0.38 (95% CI 0.27-0.55), and 0.27 (95% CI 0.18-0.40) for the second, third, and fourth versus the first anti-spike quartile; find-ings were similar by viral strain. Combining serologic and virologic screening might enable monitoring of discrete population immunologic markers and their implications for emergent variant transmission.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据